contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  createdAt
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
    forum {
      threadUrl
    }
    defaultInstrument {
      symbol
      id
    }
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    pageUrl
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
  ... on Webcast {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        threadUrl
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        symbol
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
      researchContent {
        title
        lang
        pdfUrl
        relatedContent {
          __typename
          ...PublishingDetails
          ...Reactions
          id
        }
        content {
          title
          lang
          htmlBody
          publishedAt
          createdAt
          changedAt
          isOutdated
          isPremium
        }
      }
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


scanfil-visibility-for-2026-is-looking-good-nordea

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

Scanfil is an international electronics contract manufacturer, specializing in industrial and B2B customers. Services include manufacturing of end products and components such as PCBs. Manufacturing services are the core of the company, supported by design, supply chain and modernization services. The company operates globally in Europe, America and Asia. Customers are primarily found in the process automation, energy efficiency, green efficiency and medical segments.

Inderes              Scanfil tukee TOMRAa Puolan panttijärjestelmän käyttöönotossa - Inderes    Scanfil on ollut keskeisessä roolissa TOMRAn pullonpalautusautomaattien tuotannon ylösajossa ja käyttöönotossa Puolan panttijärjestelmässä (DRS).Scanfil Oyj Lehdistötiedote 30.6.2026 klo 14....

Antti has been a busy lead analyst and has produced an extensive report on Scanfil. Like other extensive reports, this one is available for everyone to read.   We are raising our target price for Scanfil to EUR 12.50 (previously EUR 11.50) following slightly increased long-term growth forecasts. Scanfil has made good progress in recent years in implementing its playbook based on organic growth and acquisitions, and we expect this tactic to continue driving the company toward profitable growth. Due to the stock price’s robust performance over the past year, the positive earnings development in our forecasts has been priced into the share. In our view, this narrows Scanfil’s short-term return potential, even though the long-term story remains quite attractive.                    Inderes              Scanfil laaja raportti: Hyvää laatua täyteläisellä lyhyen pään hinnoittelulla...    Nostamme Scanfilin tavoitehintamme 12,50 euroon (aik. 11,50 €) lievästi nousseiden pitkän ajan kasvuennusteiden vanavedessä. Osakekurssin viimeisen vuoden väkivahvan kehityksen myötä ennusteissamme olevaa myönteistä tuloskehitystä on hinnoiteltu...                             Quotes from the report:  We expect Scanfil to continue the determined implementation of its profitable growth strategy along broadly the same lines even after 2028. In our long-term forecasts, we expect Scanfil to continue its growth driven by megatrends supporting the company’s customers and the electronics market as a whole, and on the other hand, by drivers boosting contract manufacturers. We forecast Scanfil’s revenue to grow by approximately 2–5% annually in the long term, reflecting the GDP and electronics market growth forecasts and outlooks for Scanfil’s main market areas. We have slightly raised our medium- and long-term organic growth forecasts, driven by the company’s improved performance in sales and the even slightly strengthening power of trends supporting industry growth in our projections (including the outlook for outsourcing rates). In the long run, acquisitions will very likely boost growth, and achieving the company’s growth target of over 10% is dependent on acquisitions.   Although Scanfil has quite openly indicated its aim for systematic acquisitions, we expect Scanfil to wait very patiently for suitable arrangements. This has also been the company’s historical approach. We generally view M&A positively, as Scanfil’s past arrangements have mostly been good and the fragmented structure of the industry supports consolidation. However, M&A must always be assessed on a case-by-case basis.

New PRESS release from Scanfil  Scanfil is strengthening its collaboration with the AXS division of Bruker’s Life Science & Medtech business. The collaboration currently covers, among other things, several high-end analyzers and a wide range of printed circuit board assemblies (PCBA). Scanfil is strengthening its collaboration with the AXS division of Bruker’s Life Science & Medtech business. The collaboration currently covers, among other things, several high-end analyzers and a wide range of printed circuit board assemblies (PCBA). Scanfil’s factories in Mysłowice and Pärnu provide Bruker AXS division in Germany and Belgium with PCB manufacturing, enclosures, and system assembly. The collaboration is now being expanded to other Scanfil factories to support the Bruker AXS division globally. “Our goal is to provide the Bruker AXS division with comprehensive service worldwide,” says Andreas Bohner, Global Sales Manager at Scanfil. “Our experience, advanced manufacturing solutions, and strong commitment to continuous development enable us to offer solutions for Bruker AXS’s needs. Expanding the cooperation strengthens our partnership and supports its continuous development and success.” “We are pleased to deepen our collaboration with Scanfil,” says Christian Streib, Senior Director responsible for Global Supply Chain operations at Bruker AXS. “Scanfil’s commitment to quality and its global delivery capabilities have played a key role in supporting our growth and innovation. We look forward to the continued success of our collaboration as we expand it into new areas.” The expansion of the collaboration strengthens Scanfil’s growth, particularly in Medtech & Life Science customer accounts.                   Inderes              Scanfil laajentaa yhteistyötään Brukerin Life Science & Medtech...    Scanfil vahvistaa yhteistyötään Brukerin Life Science & Medtech ‑liiketoimintaan kuuluvan AXS-divisioonan kanssa. Yhteistyö kattaa tällä hetkellä muun muassa useita korkealuokkaisia analyysaattoreita...

Hi, it will be available for purchase at Suomalainen Kirjakauppa, and there will also be at least three copies available for borrowing at the Sievi library.

Hi Pasi! How will it be possible to get this 50th-anniversary work later on if one can’t make it to the fair now?

You can find me and the Scanfil Group at the Tampere Investment Fair this week! Stop by our booth B37, and we’ll tell you why Scanfil Plc is an excellent long-term investment  In honor of our 50th anniversary, the first 40 visitors will receive a printed book that reveals how a filter manufacturer from Sievi evolved into a global electronics contract manufacturer  The book will not be officially released until June 4th, so our visitors have an excellent opportunity to be among the first to read it!  May 20, 2026  Tampere Hall See you in Tampere!

Here are Nordea’s fresh thoughts on Scanfil  We upgrade our fair value range for Scanfil to EUR  11.2-13.7 (10.4-12.7). Its hard work during 2024-25 created a good platform for organic growth with solid profitability. We also accept higher valuation multiples for Scanfil than before, due to its increased exposure to the defence sector. Acquisitions have been value-accretive. Our new fair value range is based on an equal weighting of three valuation methods: DCF, EV/EBITDA and P/E. With our estimates, Scanfil’s valuation is 10% below the peer group median 2026E-27E, but the company’s net sales and earnings growth momentum is also better than for peers on average, making risk/reward attractive, in our view. Scanfil will hold a CMD event on 29-30 September 2026, at which it could highlight its enhanced customer portfolio.                   Inderes              Scanfil: Increased defence exposure warrants higher multiples - Nordea - Inderes    We upgrade our fair value range for Scanfil to EUR 11.2-13.7 (10.4-12.7). Its hard work during 2024-25 created a good platform for organic growth with solid profitability. We also accept higher...

Scanfil

The midpoint of the full-year guidance indicates revenue growth of 25% and an EBITA margin of 7.1% for 2026. Visibility for orders looks good and the near-term outlook seems promising. Organic...

The midpoint of the full-year guidance indicates revenue growth of 25% and an EBITA margin of 7.1% for 2026. Visibility for orders looks good and the near-term outlook seems promising. Organic sales efforts have been successful, while acquisitions have broadened the customer portfolio. Due to the good operational performance, the share price has already come up by 17% year-to-date. Our fair value range remains at EUR 10.4-12.7, based on an equal weighting of three valuation methods: DCF, EV/EBITDA and P/E. On our estimates, Scanfil’s EV/EBIT multiple for 2026E is now 4% below the peer group average. The dividend proposal was EUR 0.25 (LSEG Data &amp; Analytics consensus: EUR 0.24).

Scanfil: Visibility for 2026 is looking good - Nordea

Scanfil: Visibility for 2026 is looking good - Nordea